Search Results - "Monegal, A"

Refine Results
  1. 1

    Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover by Gifre, L, Ruiz-Gaspà, S, Monegal, A, Nomdedeu, B, Filella, X, Guañabens, N, Peris, P

    Published in Bone (New York, N.Y.) (01-11-2013)
    “…Abstract The aim of this study was to analyse the effect of glucocorticoid therapy (GCCT) on Wnt signalling antagonists (sclerostin and Dkk-1) and their…”
    Get full text
    Journal Article
  2. 2

    Low serum osteocalcin levels are associated with diabetes mellitus in glucocorticoid treated patients by Florez, H., Hernández-Rodríguez, J., Carrasco, J. L., Filella, X., Prieto-González, S., Monegal, A., Guañabens, N., Peris, P.

    Published in Osteoporosis international (01-03-2022)
    “…Summary Bone turnover markers are decreased in GC-treated subjects with DM. Decreased OC levels in GC-treated patients were associated with an increased risk…”
    Get full text
    Journal Article
  3. 3

    Denosumab increases sublesional bone mass in osteoporotic individuals with recent spinal cord injury by Gifre, L., Vidal, J., Carrasco, J. L., Muxi, A., Portell, E., Monegal, A., Guañabens, N., Peris, P.

    Published in Osteoporosis international (01-01-2016)
    “…Summary Osteoporosis is a frequent complication related to spinal cord injury (SCI), and data on osteoporosis treatment after SCI is scarce. Treatment with…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Risk factors for the development of osteoporosis after spinal cord injury. A 12-month follow-up study by Gifre, L., Vidal, J., Carrasco, J. L., Muxi, A., Portell, E., Monegal, A., Guañabens, N., Peris, P.

    Published in Osteoporosis international (01-09-2015)
    “…Summary Spinal cord injury (SCI) has been associated with a marked bone loss after injury and a consequent increased risk of osteoporosis. The evaluation of…”
    Get full text
    Journal Article
  6. 6

    Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy by Gifre, L., Ruiz-Gaspà, S., Carrasco, J. L., Portell, E., Vidal, J., Muxi, A., Monegal, A., Guañabens, N., Peris, P.

    Published in Osteoporosis international (01-09-2017)
    “…Summary There is marked bone loss after spinal cord injury (SCI); however, its pathogenesis and clinical management remain unclear. The increased circulating…”
    Get full text
    Journal Article
  7. 7

    Development of multiorganic calciphylaxis during teriparatide, vitamin D, and calcium treatment by Monegal, A., Peris, P., Alsina, M., Colmenero, J., Guañabens, N.

    Published in Osteoporosis international (01-08-2016)
    “…Non-uremic calciphylaxis is a severe rare disorder characterized by ischemic necrosis. Recently, three cases of cutaneous calciphylaxis have been described in…”
    Get full text
    Journal Article
  8. 8

    Analysis of the evolution of cortical and trabecular bone compartments in the proximal femur after spinal cord injury by 3D-DXA by Gifre, L., Humbert, L., Muxi, A., Del Rio, L., Vidal, J., Portell, E., Monegal, A., Guañabens, N., Peris, P.

    Published in Osteoporosis international (2018)
    “…Summary Marked trabecular and cortical bone loss was observed at the proximal femur short-term after spinal cord injury (SCI). 3D-DXA provided measurement of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Lithocholic acid downregulates vitamin D effects in human osteoblasts by Ruiz-Gaspà, S., Guañabens, N., Enjuanes, A., Peris, P., Martinez-Ferrer, A., Martinez de Osaba, M. J., Gonzalez, B., Alvarez, L., Monegal, A., Combalia, A., Parés, A.

    Published in European journal of clinical investigation (01-01-2010)
    “…Eur J Clin Invest 2010; 40 (1): 25–34 Background  Osteoporosis is a common complication in chronic cholestasis. It has been proposed that retained substances…”
    Get full text
    Journal Article
  11. 11

    Prolonged bisphosphonate release after treatment in women with osteoporosis. Relationship with bone turnover by Peris, P, Torra, M, Olivares, V, Reyes, R, Monegal, A, Martínez-Ferrer, A, Guañabens, N

    Published in Bone (New York, N.Y.) (01-10-2011)
    “…Abstract Bisphosphonates (BP), especially alendronate and risedronate, are the drugs most commonly used for osteoporosis treatment, being incorporated into the…”
    Get full text
    Journal Article
  12. 12

    Patients with cirrhosis and ascites have false values of bone density: Implications for the diagnosis of osteoporosis by Guañabens, N., Monegal, A., Muxi, A., Martinez-Ferrer, A., Reyes, R., Caballería, J., Del Río, L., Peris, P., Pons, F., Parés, A.

    Published in Osteoporosis international (01-04-2012)
    “…Summary The effect of ascites on bone densitometry has been assessed in 25 patients with advanced cirrhosis, and it was concluded that ascites over 4 l causes…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant by Torregrosa, J.-V, Fuster, D, Monegal, A, Gentil, M. Á, Bravo, J, Guirado, L, Muxí, A, Cubero, J

    Published in Osteoporosis international (2011)
    “…Summary This study evaluates the efficacy of low doses of pamidronate after renal transplantation to prevent bone loss in osteopenic patients. Results show…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Bone disease after liver transplantation : A long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics by MONEGAL, A, NAVASA, M, GUANABENS, N, PERIS, P, PONS, F, MARTINEZ DE OSABA, M. J, ORDI, J, RIMOLA, A, RODES, J, MUNOZ-GOMEZ, J

    Published in Osteoporosis international (01-06-2001)
    “…After liver transplantation there is a high incidence of fractures, with important rates of bone loss during the first months. However, the long-term evolution…”
    Get full text
    Journal Article